160 related articles for article (PubMed ID: 15842304)
1. Regulating medicines in Europe: the European Medicines Agency, marketing authorisation, transparency and pharmacovigilance.
Permanand G; Mossialos E; McKee M
Clin Med (Lond); 2006; 6(1):87-90. PubMed ID: 16521363
[TBL] [Abstract][Full Text] [Related]
2. Licensing Requirements for Avian Vaccines Within the European Union.
Werner E; Sommer D; Rau H; Kobe B
Avian Dis; 2024 Jan; 67(4):474-479. PubMed ID: 38300666
[TBL] [Abstract][Full Text] [Related]
3. The Evolution of Drug Regulatory Sciences in the Netherlands: More than a Country Report.
Pasmooij AMG; Mol PGM; Bot JC; Leufkens HGM
Clin Pharmacol Ther; 2024 Jul; 116(1):64-71. PubMed ID: 38679943
[TBL] [Abstract][Full Text] [Related]
4. Veterinary pharmacovigilance in sub-Sahara Africa context: a pilot study of adverse reactions to veterinary medicine in Cameroon.
Mouiche MMM; Njingou BZN; Moffo F; Mpouam SE; Feussom JMK; Awah-Ndukum J
BMC Vet Res; 2019 Aug; 15(1):301. PubMed ID: 31426790
[TBL] [Abstract][Full Text] [Related]
5. Current veterinary regulations and way ahead.
Suryawanshi SJ; Jain S; Sharma RK; Chawla R; Arora S; Shukla VK; Sharma N
Res Vet Sci; 2024 Jan; 166():105101. PubMed ID: 38016218
[TBL] [Abstract][Full Text] [Related]
6. [TOPICAL ISSUES OF FUNCTIONING AND DEVELOPMENT OF THE SINGLE MARKET OF MEDICINES OF THE EURASIAN ECONOMIC UNION].
Tonkonog VV; Ananchenkova PI; Shimanovskyi NL; Vrubel ME
Probl Sotsialnoi Gig Zdravookhranenniiai Istor Med; 2023 Oct; 31(Special Issue 2):1268-1274. PubMed ID: 38069897
[TBL] [Abstract][Full Text] [Related]
7. [Legal debate about the definition of medical device and of medicinal drug for human use].
Ferge Z
Orv Hetil; 2014 Mar; 155(11):429-33. PubMed ID: 24613779
[TBL] [Abstract][Full Text] [Related]
8. Optimizing Pediatric Medicine Developments in the European Union Through Pragmatic Approaches.
Rei Bolislis W; Bejeuhr G; Benzaghou F; Corriol-Rohou S; Herrero-Martinez E; Hildebrand H; Hill-Venning C; Hoogland H; Johnson C; Joos A; Vart R; Le Visage G; Kühler TC
Clin Pharmacol Ther; 2021 Oct; 110(4):871-879. PubMed ID: 33411346
[TBL] [Abstract][Full Text] [Related]
9. Regulations Governing Medicines for Maternal and Neonatal Health: A Landscape Assessment.
Alexe A; Garg A; Kovacs B; Abramova N; Apara O; Eisele O; Fernandes MFS; Balramsingh-Harry L; Wurst K; Lewis D
Ther Innov Regul Sci; 2024 Mar; 58(2):242-257. PubMed ID: 38105314
[TBL] [Abstract][Full Text] [Related]
10. A survey of veterinary professionals in Sweden: Adverse event reporting and access to product safety information.
Mount J; Sjöström K; Arthurson V; Kreuger S
Vet Rec Open; 2021 Dec; 8(1):e18. PubMed ID: 34386242
[TBL] [Abstract][Full Text] [Related]
11. Proposed supplementary protection certificate legislation for medicinal products.
Creemer OJ; Garner S
Pharm Pat Anal; 2023 Nov; 12(6):249-252. PubMed ID: 38197380
[No Abstract] [Full Text] [Related]
12. Clinical trials for paediatric cancers under new legislation in the USA.
Hwang TJ; Reaman GH; Bourgeois FT
Lancet Child Adolesc Health; 2023 Jul; 7(7):e13. PubMed ID: 37349019
[No Abstract] [Full Text] [Related]
13. Regulating phage therapy: The biological master file concept could help to overcome regulatory challenge of personalized medicines.
Fauconnier A
EMBO Rep; 2017 Feb; 18(2):198-200. PubMed ID: 28082313
[TBL] [Abstract][Full Text] [Related]
14. Socio-historical analysis of the social importance of pharmacovigilance.
Coca JR; Coca-Asensio R; Esteban Bueno G
Front Sociol; 2022; 7():974090. PubMed ID: 36505765
[TBL] [Abstract][Full Text] [Related]
15. Veterinary dermatopathology: A growing discipline.
Affolter V; Bradley C; McMahill B; Mansell J; Roccabianca P
Vet Pathol; 2023 Nov; 60(6):722. PubMed ID: 37642394
[No Abstract] [Full Text] [Related]
16. UK veterinary professionals' perceptions and experiences of adverse drug reaction reporting.
Davies H; Pinchbeck G; Noble PM; Diesel G; Pirmohamed M; Anderson N; Killick DR
Vet Rec; 2022 Sep; 191(6):e1796. PubMed ID: 35665513
[TBL] [Abstract][Full Text] [Related]
17. Veterinary pharmacovigilance. Part 1. The legal basis in the European Union.
Woodward KN
J Vet Pharmacol Ther; 2005 Apr; 28(2):131-47. PubMed ID: 15842304
[TBL] [Abstract][Full Text] [Related]
18. Marketing authorization of veterinary medicinal products in Poland.
Sztabińska-Koncka H; Lewicki J
Regul Toxicol Pharmacol; 1997 Aug; 26(1 Pt 1):129-33. PubMed ID: 9339489
[TBL] [Abstract][Full Text] [Related]
19. Issues with regulatory pharmacovigilance in East European countries: the industry perspective.
Hanzl-Dujmović I; Sulić-Milisić Z; Staresinić-Sernhorst I
Toxicol Lett; 2007 Feb; 168(3):228-35. PubMed ID: 17161561
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
